Concepedia

Prediction Value of XRCC 1 Gene Polymorphism on the Survival of Ovarian Cancer Treated by Adjuvant Chemotherapy

Jin Miao, Xian Zhang, Qiong-Lan Tang, Xiaoyu Wang, Kai Li

Asian Pacific Journal of Cancer Prevention · 2012 · 18 citations · 23 references

DOIFull text

Open access

Abstract

This study is the first to provide evidence that XRCC1 gene polymorphisms would well be useful as surrogate markers of clinical outcome in ovarian cancer cases undergoing adjuvant chemotherapy.

References

23

<i>ERCC1</i> and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy

Yoshinori Shirota, Jan Stoehlmacher, Jan Brabender et al. · Journal of Clinical Oncology · 2001 · 607 citations

Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Wei Zhou, Sarada Gurubhagavatula, Geoffrey Liu et al. · Clinical Cancer Research · 2004 · 289 citations · Full text

ERCC1 Expression Is a Predictor of Survival in Resected Patients With Non-small Cell Lung Cancer

George R. Simon, Swati Sharma, Alan Cantor et al. · CHEST Journal · 2005 · 281 citations

, , +10

XRCC1 is required for DNA single-strand break repair in human cells

Reto Brem · Nucleic Acids Research · 2005 · 196 citations · Full text

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

Andrey Khrunin, Alexey Moisseev, Vera Gorbunova · The Pharmacogenomics Journal · 2009 · 188 citations

, , +8